Nevenka Kožuh Eržen

Linearity of eprinomectin pharmacokinetics in lactating dairy sheep following pour-on administration : Excretion in milk and exposure of suckling lambs

Pharmacokinetics of eprinomectin (EPR) were studied in blood plasma and milk in two groups of six Istrian Pramenka dairy sheep and their suckling lambs following pour-on administration of EPR to ewes at dose levels of 0.5 and 1mg/kg. Maximum concentration in plasma was 2.22 and 5.25 microg/l, and AUC was 13.6 and 33.7 microg day/l for the 0.5 and 1.0mg/kg dose, respectively. These results indicate that drug exposure with a dose of 0.5mg/kg, which is commonly used in cattle, may be subtherapeutic. The concentration time course in milk paralleled plasma concentrations. In the dose range studied, linear pharmacokinetics of EPR were demonstrated. Milk-to-plasma AUC ratio was 0.79+/-0.12 and 1.12+/-0.43; the fraction of dose recovered in milk was 0.037+/-0.011 and 0.058+/-0.027% for the low and high dose, respectively. Maximum residual levels in milk were below the maximum acceptable level of 20 microg/kg; however, EPR was detected in all samples investigated. Despite low permeability in milk, AUC in plasma of suckling lambs was between 20 and 30% of the AUC in plasma of ewes.

Factors influencing dissipation of avermectins in sheep faeces

Factors influencing fate of avermectins (abamectin, doramectin) in faeces of treated sheep were investigated under different experimental conditions. In the laboratory, concentrations of both avermectins were declined in homogenised faeces of treated animals until day 14 of exposure, regardless of experimental conditions. After that day, no significant decrease in concentrations was observed till the end of the experiment. Established DT(50) did not exceed 9 days. In the karst pasture, an average DT(50) of 27 days was established for abamectin and 23 days for doramectin in natural faeces of treated sheep. In the compost mixture, doramectin concentration was decreased by 38.9+/-2.6% during 21 days of the thermophilic phase of composting. Therefore, DT(50) was not established. A possible influence of moisture content of sheep faeces on concentrations of avermectins was observed.

The development of the method for the determination of terbinafine in cat's plasma and hair.

Abstract Clinical investigations of terbinafine indicate its high treatment activity against infections by several dermatophytes. Its efficiency was tested also in the treatment of microsporosis in cats. The distribution of terbinafine in cat’s plasma and hair is important for the identification of the drug efficiency. A fast and reliable reversed-phase high performance liquid chromatographic method with appropriate sample preparation has been developed.Reliability, good reproducibility and low detection limit (LOD 0.25 ng/ml) of the method enable determination of terbinafine in hair and also in plasma of cats infected with Microsporum canis treated by Lamisil® tablets.